Biotech startups that raised Series B in Seoul-t'ukpyolsi, South Korea
Updated 16 Nov 2026
Not sure about the data?
Download a free 10-row sample first. No account, no payment.
| Company | City | Last round | Amount | Date |
|---|---|---|---|---|
| HITS | Seoul | Series B | $13.5M | 2026-09-28 |
| Galux | Dogokdong | Series B | $29.0M | 2026-02-09 |
| Avelos Therapeutics | Seoul | Series B | $12.4M | 2024-05-02 |
| Surginex | Seocho | Series B | $6.3M | 2024-03-28 |
| NeoCannBio | Seoul | Series B | $7.4M | 2023-09-26 |
| Cell Lab Med | Seoul | Series B | $19.7M | 2021-11-15 |
| Cell in Cells | Seoul | Series B | $10.4M | 2021-07-26 |
7 rows of the CSV in 5 of its 18 columns.
- The 34 biotech startups in Seoul-t'ukpyolsi, South Korea whose last round is Series B have raised $322.3M in total.
- 6 of them closed their most recent round in the last 12 months, $88.4M combined.
- The largest of those rounds is Galux's $29.0M Series B, dated February 2026.
- The most recent is NexThera's $16.2M Series B on 28 September 2026.
- Kiwoom Investment is an investor in 2 of them, more than any other fund.
- Health care is the most common other sector, with 29 companies (85%).
- 29% were founded in 2020 or later; the median founding year is 2018.
- The most common team size is 11 to 50 employees (72% of companies with a recorded size).
Source: FundingWatcher. Data as of 16 November 2026. "Last 12 months" is the 365 days to that date.
Newest rounds
4 of 34| Company | What they do | Sector | City | Last round | Amount | Date | Total raised | Investors | Employees | Founded |
|---|---|---|---|---|---|---|---|---|---|---|
| HITS | HITS develops artificial intelligence software for drug discovery and pharmaceutical research. | Artificial intelligence | Seoul | Series B | $13.5M | 2026-09-28 | $25.1M | Korea Investment Partners, Capstone Partners, Company K Partners +2 | 11 to 50 | 2020 |
| Galux | Galux designs molecules to discover new drugs for incurable and rare diseases. | Artificial intelligence | Dogokdong | Series B | $29.0M | 2026-02-09 | $36.3M | Dayli Partners | 11 to 50 | 2020 |
| Surginex | Surginex develops biological drugs and offers molecular biology, genetics, and physical and chemical analysis services. | Biotech | Seocho | Series B | $6.3M | 2024-03-28 | Hana Ventures, Laguna Investment, Partners Investment +1 | 1 to 10 | 2020 | |
| Plcoskin | Plcoskin is a MedTech company that offers reconstructive plastic surgery and regenerative skincare. | Biotech | Seoul | Series B | $4.5M | 2023-08-31 | TIPS Program, Primer, We Ventures +1 | 11 to 50 | 2018 |
Table 1. Biotech startups that raised Series B in Seoul-t'ukpyolsi, South Korea: the 4 newest rounds whose row carries a description, a city, a named fund and an amount. Source: FundingWatcher. Data as of 16 November 2026. Base: 34.
Largest rounds
Last 12 months| # | Company | What they do | Sector | City | Last round | Amount | Date | Total raised | Investors | Employees | Founded |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Galux | Galux designs molecules to discover new drugs for incurable and rare diseases. | Artificial intelligence | Dogokdong | Series B | $29.0M | 2026-02-09 | $36.3M | Dayli Partners | 11 to 50 | 2020 |
| 2 | HITS | HITS develops artificial intelligence software for drug discovery and pharmaceutical research. | Artificial intelligence | Seoul | Series B | $13.5M | 2026-09-28 | $25.1M | Korea Investment Partners, Capstone Partners, Company K Partners +2 | 11 to 50 | 2020 |
Table 2. Biotech startups that raised Series B in Seoul-t'ukpyolsi, South Korea: the 2 largest rounds of the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.
Most active investors
By companies backed| # | Investor | Type | Location | Companies | Share | Funded, 12 months | Latest |
|---|---|---|---|---|---|---|---|
| 1 | Kiwoom Investment | Venture capital firm | Youidodong, South Korea | 2 | 6% | 1 | HITS |
| 2 | Korea Investment Partners | Private equity firm | Seoul, South Korea | 2 | 6% | 1 | HITS |
| 3 | Capstone Partners | Venture capital firm | Seoul, South Korea | 1 | 3% | 1 | HITS |
| 4 | STIC Ventures | Venture capital firm | Seoul, South Korea | 1 | 3% | 1 | HITS |
| 5 | Company K Partners | Venture capital firm | Ilsangu, South Korea | 1 | 3% | 1 | HITS |
| 6 | Dayli Partners | Venture capital firm | Seoul, South Korea | 1 | 3% | 1 | Galux |
| 7 | Mirae Asset Venture Investment | Venture capital firm | Seongnam, South Korea | 1 | 3% | ||
| 8 | UTC Investment Co. | Venture capital firm | Seoul, South Korea | 1 | 3% | ||
| 9 | SV Investment Corp | Venture capital firm | Seoul, South Korea | 1 | 3% | ||
| 10 | Mirae Asset Capital | Investment bank | Seoul, South Korea | 1 | 3% | ||
| 11 | Partners Investment | Venture capital firm | Seoul, South Korea | 1 | 3% | ||
| 12 | Laguna Investment | Venture capital firm | Seoul, South Korea | 1 | 3% | ||
| 13 | Hana Ventures | Corporate venture arm | Seoul, South Korea | 1 | 3% | ||
| 14 | Bilanx Investment | Venture capital firm | Seoul, South Korea | 1 | 3% | ||
| 15 | Prologue Ventures | Venture capital firm | Birmingham, United States | 1 | 3% |
Table 3. Biotech startups that raised Series B in Seoul-t'ukpyolsi, South Korea: the funds recorded as investors in the most companies. Latest: companies they back that raised in the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.
Sectors
| Sectors | Companies | Share | Total raised |
|---|---|---|---|
| Health care | 29 | 85% | $308.1M |
| Software | 5 | 15% | $74.9M |
| Artificial intelligence | 3 | 9% | $61.4M |
| Hardware | 3 | 9% | $24.0M |
| Cybersecurity | 1 | 3% |
Table 4. Biotech startups that raised Series B in Seoul-t'ukpyolsi, South Korea by sector. Source: FundingWatcher. Data as of 16 November 2026.
Funding stage
| Funding stage | Companies | Share | Median last round |
|---|---|---|---|
| Series B | 34 | 100% | $10.4M |
Table 5. Biotech startups that raised Series B in Seoul-t'ukpyolsi, South Korea by stage of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.
Cities
| Cities | Companies | Share |
|---|---|---|
| Seoul | 25 | 74% |
| Songpadong | 3 | 9% |
| Seocho | 2 | 6% |
| Jungang | 1 | 3% |
| Dogokdong | 1 | 3% |
| Mapo | 1 | 3% |
| Doksansadong | 1 | 3% |
Table 6. Biotech startups that raised Series B in Seoul-t'ukpyolsi, South Korea by headquarters city. Source: FundingWatcher. Data as of 16 November 2026.
Rounds by month
| Rounds by month | Companies | Share | Raised |
|---|---|---|---|
| September 2026 | 3 | 50% | $35.6M |
| June 2026 | 1 | 17% | $14.0M |
| February 2026 | 1 | 17% | $29.0M |
| December 2025 | 1 | 17% | $9.9M |
Table 7. Biotech startups that raised Series B in Seoul-t'ukpyolsi, South Korea: most recent round by month, last 12 months. Source: FundingWatcher. Data as of 16 November 2026.
Most recent round by year
| Most recent round by year | Companies | Share | Raised |
|---|---|---|---|
| 2026 | 5 | 15% | $78.6M |
| 2025 | 4 | 12% | $58.3M |
| 2024 | 2 | 6% | $18.7M |
| 2023 | 6 | 18% | $41.1M |
| 2022 | 8 | 24% | $89.7M |
| 2021 | 4 | 12% | $70.5M |
Table 8. Biotech startups that raised Series B in Seoul-t'ukpyolsi, South Korea by year of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.
Founding year
| Founding year | Companies | Share |
|---|---|---|
| 2020 to 2022 | 10 | 29% |
| 2015 to 2019 | 17 | 50% |
| 2010 to 2014 | 5 | 15% |
| Before 2010 | 2 | 6% |
Table 9. Biotech startups that raised Series B in Seoul-t'ukpyolsi, South Korea by founding year. Source: FundingWatcher. Data as of 16 November 2026.
Team size
| Team size | Companies | Share |
|---|---|---|
| 1 to 10 | 6 | 19% |
| 11 to 50 | 23 | 72% |
| 51 to 100 | 3 | 9% |
Table 10. Biotech startups that raised Series B in Seoul-t'ukpyolsi, South Korea by headcount. Source: FundingWatcher. Data as of 16 November 2026.
Method
- A company is on this list when Biotech is one of its sectors and its most recent funding round is Series B and its headquarters is in Seoul-t'ukpyolsi, South Korea. On 16 November 2026 that is 34 companies.
- Stage, round, amount and date are those of the company's most recent funding round. Amounts are in US dollars as the source records them.
- The table prints the 4 newest rounds whose row is complete: a one-sentence description, a city, a named fund and an amount. The CSV carries all 34 rows: 2 have no round amount, 0 no city and 7 no website. The CSV carries domain, website, LinkedIn and the cached description sentence where present.
Sources, fields and exclusions of both files: Method.
Questions
- How many biotech startups in Seoul-t'ukpyolsi, South Korea whose last round is Series B are on the list?
- 34, in the file dated 16 November 2026. 6 of them closed their most recent round in the last 12 months.
- What does the CSV contain?
- One row per company, 18 columns: name, domain, website, linkedin, description, founded, employees, city, region, country, sectors, funding_stage, last_round, last_round_date, last_round_usd, total_raised_usd, rounds, investors.
- How much does the list cost?
- $29 one-time for all 34 rows, no account. Every investor and every startup, two files, cost $99. With founder contacts, up to 2 founders or CEOs per company compiled to order and mailed within 24 hours, $199.
- What arrives after payment?
- At once: the CSV download link, on the page after payment and by mail.
- Can I see rows before buying?
- The 3 rows under the buy button are rows of the CSV with every column. The form below it mails 10 rows.
- How current is the data?
- The file is dated 16 November 2026. The download link serves the current file each time it is opened.
Not sure about the data?
Download a free 10-row sample first. No account, no payment.